Peptide Research
Beyond Retatrutide: First Quintuple Agonist Obesity Drug Could Change the Weight Loss Race
The obesity treatment market is moving faster than ever. First came GLP-1 medications like semaglutide. Then dual agonists such as
Retatrutide (GLP-3) Explained: Why This Triple Agonist Is Getting So Much Attention in Research
Retatrutide has rapidly become one of the most discussed investigational compounds in modern peptide and metabolic research. Much of that
Peptide Shipping Myth: Do Peptides Need Ice or Cold Shipping?
The Truth About Summer Shipping, Delays, and Lyophilized Peptide Stability Every year—especially during summer—we get the same worried message: “My
Structure’s Aleniglipron: Study Results, Oral GLP-1 Comparison, and Key Data
Structure Therapeutics has officially entered the serious oral GLP-1 conversation. Its once-daily oral study drug, aleniglipron, delivered one of the
Dihexa Research Compound: Mechanism, BDNF, HGF/c-Met & Laboratory Research
What Is Dihexa? Dihexa is a synthetic angiotensin IV-derived peptidomimetic compound that has become a topic of interest in preclinical
Amycretin vs GLP-1-Based Peptides: A Research-Based Comparison Guide (2026)
The Evolution of Metabolic Research Compounds The metabolic research space has shifted rapidly from single-pathway compounds to multi-mechanism designs aimed